CHEMORADIOTHERAPY
Clinical trials for CHEMORADIOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new CHEMORADIOTHERAPY trials appear
Sign up with your email to follow new studies for CHEMORADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy combo aims to improve lung cancer outcomes
Disease control Not yet recruitingThis phase II trial tests an immunotherapy drug called SHR-1701 combined with chemotherapy and radiation for people with unresectable stage III non-small cell lung cancer. The study will enroll 84 participants and compare giving SHR-1701 before or after standard chemoradiation. T…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New targeted pill may keep ALK lung cancer in check after standard treatment
Disease control Not yet recruitingThis study tests whether the targeted drug ensartinib can help people with ALK-mutated stage III lung cancer that cannot be removed by surgery. After completing standard chemoradiotherapy, 45 participants will receive either ensartinib or a placebo to see if the drug delays cance…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can MRI scans spare rectal cancer patients from unnecessary surgery?
Knowledge-focused Not yet recruitingThis study aims to develop a method using advanced MRI scans to predict whether rectal cancer has been completely eliminated after chemoradiation. About 115 patients will be enrolled to test the accuracy of this MRI-based prediction. If it works, some patients might safely avoid …
Matched conditions: CHEMORADIOTHERAPY
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC